Burcon Nutrascience Corporation (BU.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 37 | 100 | 148 | 372 | 660 |
| Accounts receivable | -206 | 28 | 9 | -12 | -7 |
| Accounts payable and accrued liabilities | 40 | -140 | 257 | -101 | -8 |
| Other Working Capital | -4 | -190 | 215 | -121 | -38 |
| Other Operating Activity | -2,606 | -3,944 | -5,253 | -4,746 | -5,491 |
| Operating Cash Flow | $-2,738 | $-4,147 | $-4,624 | $-4,607 | $-4,884 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -101 | -19 | -20 | -138 | -60 |
| Net Acquisitions | -13,000 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,467 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1,371 |
| Investing Cash Flow | $-14,568 | $-19 | $-20 | $-138 | $1,311 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,296 | 1,250 | N/A | N/A | N/A |
| Debt Issued | 9,500 | N/A | 0 | 2,000 | N/A |
| Debt Repayment | -2,509 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 25,752 | 0 | 3,485 | 5,136 | 3,843 |
| Other Financing Activity | 399 | -18 | -106 | -190 | -132 |
| Financing Cash Flow | $31,846 | $1,232 | $3,380 | $6,946 | $3,711 |
| Exchange Rate Effect | 2 | 2 | -16 | 21 | -60 |
| Beginning Cash Position | 489 | 3,421 | 4,701 | 2,480 | 2,401 |
| End Cash Position | 15,031 | 489 | 3,421 | 4,701 | 2,480 |
| Net Cash Flow | $14,540 | $-2,934 | $-1,264 | $2,201 | $139 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,738 | -4,147 | -4,624 | -4,607 | -4,884 |
| Capital Expenditure | -1,568 | -19 | -20 | -157 | -60 |
| Free Cash Flow | -4,306 | -4,166 | -4,644 | -4,764 | -4,943 |